Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,745 public trials 3,146 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

NCT06516653

Conditions
Chronic Disease, Disease Attributes, End Stage Renal Disease, +11 more
Locations
  • Fresenius Vascular Care Long Beach Long Beach, California, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
  • Grady Memorial Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

NCT07101640

Conditions
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of Massachusetts Amherst, Massachusetts, United States
  • University Medical Center of Southern Nevada Las Vegas, Nevada, United States
  • University of North Carolina (UNC) Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

NCT05184816

Conditions
Central Nervous System Neoplasms, Disease Attributes, Leptomeningeal Metastases, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

NCT05371808

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
  • Lakeridge Health Oshawa Oshawa, Ontario, Canada
View Trial Details
Recruiting

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

NCT05533697

Conditions
Advanced Solid Tumors, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
View all 39 locations
View Trial Details
Recruiting

Colchicine in Chronic Limb-Threatening Ischemia

NCT07536373

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
Locations
  • Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan
  • Chi Mei Medical Center Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Taipei Veterans General Hospital Taipei, Taiwan
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates PC Birmingham, Alabama, United States
  • Ctr for Neurology and Spine Phoenix, Arizona, United States
  • AZ Integrated Neuro and Spine Phoenix, Arizona, United States
  • Center for Neurosciences Tucson, Arizona, United States
View all 236 locations
View Trial Details

Related conditions